Status:
RECRUITING
Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
Lead Sponsor:
Fundación Sociedad Española de Oncologia Médica
Conditions:
Thromboembolism
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Epidemiological, observational, non-interventional, multicentric study on patients diagnosed with cancer who develop a venous or arterial thromboembolic episode, symptomatic or incidental, within a mo...
Eligibility Criteria
Inclusion
- Over 18 years of age with a histologically confirmed diagnosis of malignant tumor.
- Venous or arterial thromboembolism episode, symptomatic or incidental, in the month prior or any time after the cancer diagnosis and in the three previous months to enrollment, confirmed with an imaging technique: Doppler echocardiography, computed tomography (CT) angiography, etc.
- Signing of informed consent.
Exclusion
- Clinical diagnosis of thromboembolic event without radiological confirmation.
- Presenting a single episode of superficial thrombophlebitis without association with another thromboembolic event.
- Each patient will be recorded just once, and therefore a second thromboembolic event will be considered a rethrombosis and will be recorded as such. Patients with a rethrombosis and a previous thromboembolic event before the start of the study in each center will not be able to be included.
Key Trial Info
Start Date :
July 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT03855592
Start Date
July 4 2018
End Date
July 1 2026
Last Update
May 16 2025
Active Locations (48)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Virgen de los Lirios
Alcoy, Alicante, Spain
2
Hospital Universitario de Torrevieja
Elche, Alicante, Spain
3
Hospital Son Espases
Palma, Balearic Islands, Spain
4
Institut Català D'Oncologia (ICO) L'Hospitalet
L'Hospitalet de Llobregat, Barcelona, Spain